Global X China Biotech ETF (02820.HK) Falls 6.72% to HKD 66.400

Newtimespace News: As of 13:31 on July 17, Global X China Biotech ETF (02820.HK) stood at HKD 66.400, down 6.72%. The ETF opened at HKD 70.600, with the latest net asset value (NAV) at HKD 71.213, a discount of 0.05%, a turnover of approximately HKD 1.0584 million, and assets under management of approximately HKD 655 million.

Global X China Biotech ETF (02820.HK) closely tracks the Solactive China Biotech Index (Net Total Return). The index focuses on China's biotech sector, covering biopharmaceuticals, vaccine development, gene sequencing, medical devices, and other subsectors, capturing investment opportunities arising from innovation and upgrading in China's biotech industry.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.